A single-scan protocol for absolute D2/3 receptor quantification with [123I]IBZM SPECT
暂无分享,去创建一个
Philippe Millet | Benjamin B. Tournier | Nathalie Ginovart | Stergios Tsartsalis | Selim Habiby | Karl Aoun | Diego Pandolfo | Andrea Dimiziani | N. Ginovart | P. Millet | B. Tournier | S. Tsartsalis | Andrea Dimiziani | Karl Aoun | Selim Habiby | Diego Pandolfo
[1] Vincent J. Cunningham,et al. Parametric Imaging of Ligand-Receptor Binding in PET Using a Simplified Reference Region Model , 1997, NeuroImage.
[2] S. D. Glick,et al. Neurochemical and behavioral differences between d-methamphetamine and d-amphetamine in rats , 2003, Psychopharmacology.
[3] P B Hoffer,et al. Microdialysis and SPECT measurements of amphetamine‐induced dopamine release in nonhuman primates , 1997, Synapse.
[4] Sylvain Houle,et al. Amphetamine pretreatment induces a change in both D2-Receptor density and apparent affinity: a [11C]raclopride positron emission tomography study in cats , 2004, Biological Psychiatry.
[5] J Delforge,et al. Quantitation of benzodiazepine receptors in human brain using the partial saturation method. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[6] Nathalie Ginovart,et al. Imaging the Dopamine System with In Vivo [11C]raclopride Displacement Studies: Understanding the True Mechanism , 2005, Molecular Imaging and Biology.
[7] Philippe Millet,et al. Evaluation of the Reference Tissue Models for PET and SPECT Benzodiazepine Binding Parameters , 2002, NeuroImage.
[8] N. Volkow,et al. Reduced sleep duration mediates decreases in striatal D2/D3 receptor availability in cocaine abusers , 2016, Translational Psychiatry.
[9] N. Ginovart,et al. In Vivo Quantification of 5-HT2A Brain Receptors in Mdr1a KO Rats with 123I-R91150 Single-Photon Emission Computed Tomography , 2015, Molecular imaging.
[10] José Guimón,et al. Wavelet Analysis of Dynamic PET Data: Application to the Parametric Imaging of Benzodiazepine Receptor Concentration , 2000, NeuroImage.
[11] D J Brooks,et al. Comparison of Methods for Analysis of Clinical [11C]Raclopride Studies , 1996, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[12] G. Arbuthnott,et al. Amphetamine‐Induced Dopamine Release in the Rat Striatum: An In Vivo Microdialysis Study , 1988, Journal of neurochemistry.
[13] N. Harada,et al. Is synaptic dopamine concentration the exclusive factor which alters the in vivo binding of [ 11 C ]raclopride?: PET studies combined with microdialysis in conscious monkeys , 1999, Brain Research.
[14] Mark Slifstein,et al. The nature of dopamine dysfunction in schizophrenia and what this means for treatment. , 2012, Archives of general psychiatry.
[15] G. Searle,et al. The Simplified Reference Tissue Model: Model Assumption Violations and Their Impact on Binding Potential , 2015, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[16] Nora D. Volkow,et al. Hyperstimulation of striatal D2 receptors with sleep deprivation: Implications for cognitive impairment , 2009, NeuroImage.
[17] J. Schiefer,et al. Cerebral kinetics of the dopamine D(2) receptor ligand [(123)I]IBZM in mice. , 2008, Nuclear medicine and biology.
[18] François Mauguière,et al. Seizure-related short-term plasticity of benzodiazepine receptors in partial epilepsy: a [11C]flumazenil-PET study. , 2005, Brain : a journal of neurology.
[19] Jeih-San Liow,et al. Cerebellum Can Serve As a Pseudo-Reference Region in Alzheimer Disease to Detect Neuroinflammation Measured with PET Radioligand Binding to Translocator Protein , 2015, The Journal of Nuclear Medicine.
[20] Doris J Doudet,et al. Sequential Versus Nonsequential Measurement of Density and Affinity of Dopamine D2 Receptors with [11C]raclopride: Effect of Methamphetamine , 2003, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[21] Mitul A. Mehta,et al. The dopaminergic basis of human behaviors: A review of molecular imaging studies , 2009, Neuroscience & Biobehavioral Reviews.
[22] N. Alpert,et al. Concentration of dopamine transporters: To Bmax or not to Bmax? , 1999, Synapse.
[23] M. Grégoire,et al. In Vivo Measurement of Hippocampal GABAA/cBZR Density with [18F]-Flumazenil PET for the Study of Disease Progression in an Animal Model of Temporal Lobe Epilepsy , 2014, PloS one.
[24] Mary L. Schneider,et al. The effects of chronic alcohol self-administration on serotonin-1A receptor binding in nonhuman primates. , 2014, Drug and alcohol dependence.
[25] B Walder,et al. Similarity and Robustness of PET and SPECT Binding Parameters for Benzodiazepine Receptors , 2000, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[26] L Cinotti,et al. Parameter and index images of benzodiazepine receptor concentration in the brain. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[27] Philippe Millet,et al. Quantification of dopamine D2/3 receptors in rat brain using factor analysis corrected [18F]Fallypride images , 2012, NeuroImage.
[28] S. Kapur,et al. Role of dopamine D(2) receptors for antipsychotic activity. , 2012, Handbook of experimental pharmacology.
[29] Multiinjection Approach for D2 Receptor Binding Quantification in Living Rats using [11C]Raclopride and the β-Microprobe: Crossvalidation with in Vitro Binding Data , 2005, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[30] J. Delforge,et al. Identifiability analysis and parameter identification of an in vivo ligand-receptor model from PET data , 1990, IEEE Transactions on Biomedical Engineering.
[31] J. P. Bazin,et al. Handling of Dynamic Sequences in Nuclear Medicine , 1982, IEEE Transactions on Nuclear Science.
[32] N. Volkow,et al. Distribution Volume Ratios without Blood Sampling from Graphical Analysis of PET Data , 1996, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[33] N. Ginovart,et al. Quantification of GABAA receptors in the rat brain with [(123)I]Iomazenil SPECT from factor analysis-denoised images. , 2014, Nuclear medicine and biology.
[34] Philippe Millet,et al. In vivo quantification of 5-HT1A–[18F]MPPF interactions in rats using the YAP-(S)PET scanner and a β-microprobe , 2008, NeuroImage.
[35] Frank Telang,et al. Sleep Deprivation Decreases Binding of [11C]Raclopride to Dopamine D2/D3 Receptors in the Human Brain , 2008, The Journal of Neuroscience.
[36] M Slifstein,et al. Derivation of [(11)C]WAY-100635 binding parameters with reference tissue models: effect of violations of model assumptions. , 2000, Nuclear medicine and biology.
[37] D. Sibley,et al. Dopamine β‐hydroxylase‐deficient mice have normal densities of D2 dopamine receptors in the high‐affinity state based on in vivo PET imaging and in vitro radioligand binding , 2010, Synapse.
[38] F. Beekman,et al. SPECT imaging of D2 dopamine receptors and endogenous dopamine release in mice , 2008, European Journal of Nuclear Medicine and Molecular Imaging.
[39] J. Holden,et al. Sequential versus Nonsequential Measurement of Density and Affinity of Dopamine D2 Receptors with [11C]Raclopride: 2: Effects of DAT Inhibitors , 2006, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[40] M. Mintun,et al. A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography , 1984, Annals of neurology.
[41] N. Verhoeff,et al. In vitro and in vivo D2-dopamine receptor binding with [123I]S(-) iodobenzamide ([123I]IBZM) in rat and human brain. , 1991, International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology.
[42] Frederic Boisson,et al. Simulation-based optimisation of the PET data processing for Partial Saturation Approach protocols , 2014, NeuroImage.
[43] Mary L. Schneider,et al. Measurement of 5-HT1A Receptor Density and in-vivo Binding Parameters of [18F]mefway in the Nonhuman Primate , 2012, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[44] Dean F. Wong,et al. Dissociative Changes in the Bmax and KD of Dopamine D2/D3 Receptors with Aging Observed in Functional Subdivisions of the Striatum: A Revisit with an Improved Data Analysis Method , 2012, The Journal of Nuclear Medicine.
[45] M. Laruelle,et al. Baseline and Amphetamine-Stimulated Dopamine Activity Are Related in Drug-Naïve Schizophrenic Subjects , 2009, Biological Psychiatry.
[46] R. P. Maguire,et al. Consensus Nomenclature for in vivo Imaging of Reversibly Binding Radioligands , 2007, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[47] P. Millet,et al. SPECT quantification of benzodiazepine receptor concentration using a dual-ligand approach. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[48] S. Kapur,et al. In vivo evidence for dopamine-mediated internalization of D2-receptors after amphetamine: differential findings with [3H]raclopride versus [3H]spiperone. , 2003, Molecular pharmacology.
[49] Dennis Hernaus,et al. The dopaminergic response to acute stress in health and psychopathology: A systematic review , 2015, Neuroscience & Biobehavioral Reviews.
[50] Diana Martinez,et al. Cocaine abuse and sensitization of striatal dopamine transmission: A critical review of the preclinical and clinical imaging literature , 2008, Synapse.
[51] C. Louapre,et al. The neuronal component of gray matter damage in multiple sclerosis: A [11C]flumazenil positron emission tomography study , 2015, Annals of neurology.
[52] C. Svarer,et al. High trait aggression in men is associated with low 5-HT levels, as indexed by 5-HT4 receptor binding. , 2016, Social cognitive and affective neuroscience.
[53] N. Volkow,et al. Imaging dopamine's role in drug abuse and addiction , 2009, Neuropharmacology.
[54] S. Zoghbi,et al. Evaluation of ultrafiltration for the free-fraction determination of single photon emission computed tomography (SPECT) radiotracers: beta-CIT, IBF, and iomazenil. , 1994, Journal of pharmaceutical sciences.
[55] D. Segal,et al. Concomitant characterization of behavioral and striatal neurotransmitter response to amphetamine using in vivo microdialysis , 1989, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[56] N. Volkow,et al. Dopamine D2 Receptor Availability in Opiate-Dependent Subjects before and after Naloxone-Precipitated Withdrawal , 1997, Neuropsychopharmacology.
[57] J. Delforge,et al. Parametric Images of Benzodiazepine Receptor Concentration Using a Partial-Saturation Injection , 1997, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[58] J Delforge,et al. Experimental design optimisation: theory and application to estimation of receptor model parameters using dynamic positron emission tomography. , 1989, Physics in medicine and biology.
[59] 5-HT2A receptor SPECT imaging with [¹²³I]R91150 under P-gp inhibition with tariquidar: More is better? , 2016, Nuclear medicine and biology.
[60] J. Schiefer,et al. Comparison of intravenous and intraperitoneal [123I]IBZM injection for dopamine D2 receptor imaging in mice. , 2008, Nuclear medicine and biology.
[61] A. Lammertsma,et al. Simplified Reference Tissue Model for PET Receptor Studies , 1996, NeuroImage.
[62] W. van den Brink,et al. Varenicline increases in vivo striatal dopamine D2/3 receptor binding: an ultra-high-resolution pinhole [123I]IBZM SPECT study in rats. , 2012, Nuclear medicine and biology.
[63] S. Kapur,et al. Mechanisms underlying psychosis and antipsychotic treatment response in schizophrenia: insights from PET and SPECT imaging. , 2009, Current pharmaceutical design.
[64] Alan A. Wilson,et al. Positron Emission Tomography Quantification of [11C]-DASB Binding to the Human Serotonin Transporter: Modeling Strategies , 2001, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[65] L. Howell,et al. Neuroimaging and drug taking in primates , 2011, Psychopharmacology.
[66] Anat Biegon,et al. Serial microPET measures of the metabolic reaction to a microdialysis probe implant , 2006, Journal of Neuroscience Methods.
[67] A. Malhotra,et al. Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: evidence from a novel positron emission tomography method. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[68] Swen Hesse,et al. Kinetic analyses of [123I]IBZM SPECT for quantification of striatal dopamine D2 receptor binding: A critical evaluation of the single-scan approach , 2008, NeuroImage.
[69] Doris J Doudet,et al. Raclopride studies of dopamine release: dependence on presynaptic integrity , 2003, Biological Psychiatry.
[70] Bernard Bendriem,et al. Quantitation of Extrastriatal D2 Receptors Using a Very High-Affinity Ligand (FLB 457) and the Multi-Injection Approach , 1999, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[71] Anthonin Reilhac,et al. A data driven method for estimation of Bavail and appKD using a single injection protocol with [11C]raclopride in the mouse , 2014, NeuroImage.
[72] N. Volkow,et al. Association between striatal dopamine D2/D3 receptors and brain activation during visual attention: effects of sleep deprivation , 2016, Translational psychiatry.
[73] C. Antke,et al. Binding of [123I]iodobenzamide to the rat D2 receptor after challenge with various doses of methylphenidate: an in vivo imaging study with dedicated small animal SPECT , 2011, European Journal of Nuclear Medicine and Molecular Imaging.
[74] Doris J Doudet,et al. In Vivo Measurement of Receptor Density and Affinity: Comparison of the Routine Sequential Method with a Nonsequential Method in Studies of Dopamine D2 Receptors with [11C]Raclopride , 2003, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[75] Sonja W. Scholz,et al. Evaluation of [123I]IBZM pinhole SPECT for the detection of striatal dopamine D2 receptor availability in rats , 2005, NeuroImage.
[76] M. Laruelle. Imaging Synaptic Neurotransmission with in Vivo Binding Competition Techniques: A Critical Review , 2000, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[77] R. Innis,et al. Applications of SPECT imaging of dopaminergic neurotransmission in neuropsychiatric disorders , 2000, Annals of nuclear medicine.
[78] Robert B. Innis,et al. Serotonin-1A receptors in major depression quantified using PET: Controversies, confounds, and recommendations , 2012, NeuroImage.
[79] Bernard Bendriem,et al. Modeling Analysis of [11C]Flumazenil Kinetics Studied by PET: Application to a Critical Study of the Equilibrium Approaches , 1993, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[80] M. Slifstein,et al. Deficits in Dopamine D2 Receptors and Presynaptic Dopamine in Heroin Dependence: Commonalities and Differences with Other Types of Addiction , 2012, Biological Psychiatry.
[81] J. Swanson,et al. Dopamine in drug abuse and addiction: results of imaging studies and treatment implications. , 2007, Archives of neurology.
[82] Bradley T. Christian,et al. 5-HT1A sex based differences in Bmax, in vivo KD, and BPND in the nonhuman primate , 2013, NeuroImage.